A detailed history of Groupama Asset Managment transactions in Insulet Corp stock. As of the latest transaction made, Groupama Asset Managment holds 1,050,517 shares of PODD stock, worth $276 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,050,517
Previous 3,405 30752.19%
Holding current value
$276 Million
Previous $687 Million 60.81%
% of portfolio
0.03%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$180.69 - $239.01 $189 Million - $250 Million
1,047,112 Added 30752.19%
1,050,517 $1.1 Billion
Q2 2024

Aug 14, 2024

BUY
$161.02 - $206.98 $459,873 - $591,134
2,856 Added 520.22%
3,405 $687 Million
Q1 2024

May 14, 2024

BUY
$163.6 - $209.11 $8,834 - $11,291
54 Added 10.91%
549 $94.1 Million
Q4 2023

Feb 14, 2024

BUY
$127.77 - $221.42 $63,246 - $109,602
495 New
495 $107 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.2B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.